Published in Head Neck on November 01, 2004
IMRT in oral cavity cancer. Radiat Oncol (2007) 1.16
Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer. BMC Cancer (2011) 0.98
Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy. Strahlenther Onkol (2011) 0.93
TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors. J Transl Med (2013) 0.92
Current management of advanced resectable oral cavity squamous cell carcinoma. Clin Exp Otorhinolaryngol (2011) 0.86
Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma. Cell Death Dis (2015) 0.85
Emphasizing conformal avoidance versus target definition for IMRT planning in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 0.83
Buccal mucosa carcinoma: surgical margin less than 3 mm, not 5 mm, predicts locoregional recurrence. Radiat Oncol (2010) 0.82
High-level β1-integrin expression in a subpopulation of highly tumorigenic oral cancer cells. Clin Oral Investig (2013) 0.82
Postoperative radiotherapy for squamous cell carcinoma of the head and neck. Clin Med Res (2006) 0.82
The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: a Markov decision analysis approach. Laryngoscope (2011) 0.81
Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg (2013) 0.79
Delayed postoperative radiation therapy in local control of squamous cell carcinoma of the tongue and floor of the mouth. Einstein (Sao Paulo) (2015) 0.78
Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases. Eur Arch Otorhinolaryngol (2015) 0.78
Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy. Radiat Oncol (2006) 0.78
Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue. Oral Oncol (2013) 0.77
Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases. Strahlenther Onkol (2011) 0.76
Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers. JAMA Otolaryngol Head Neck Surg (2017) 0.75
Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy. Front Oncol (2017) 0.75
Evaluation of Lymphatic and Vascular Invasion in Relation to Clinicopathological Factors and Treatment Outcome in Oral Cavity Squamous Cell Carcinoma. Medicine (Baltimore) (2015) 0.75
Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers. Head Neck (2014) 0.75
Interobserver Variation Among Pathologists in Evaluating Perineural Invasion for Oral Squamous Cell Carcinoma. Head Neck Pathol (2016) 0.75
Perineural Spread in Noncutaneous Head and Neck Cancer: New Insights into an Old Problem. J Neurol Surg B Skull Base (2016) 0.75
Outcome and fewer indications for adjuvant therapy for patients with oral squamous cell carcinomas under standardized tumor board conditions. J Cancer Res Clin Oncol (2015) 0.75
Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA (2003) 3.93
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol (2006) 2.68
Proton therapy for prostate cancer. Oncology (Williston Park) (2011) 2.11
Radiotherapy for pleomorphic adenoma. Am J Otolaryngol (2012) 2.04
Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 1.97
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
Management of T1-T2 glottic carcinomas. Cancer (2004) 1.87
Ameloblastoma. Am J Clin Oncol (2007) 1.81
Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer (2002) 1.76
Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys (2007) 1.62
External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys (2002) 1.60
Cutaneous angiosarcoma. Am J Clin Oncol (2006) 1.60
Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck (2004) 1.59
Head and neck squamous cell carcinoma from an unknown primary site. Am J Otolaryngol (2010) 1.58
Head and neck mucosal melanoma. Am J Clin Oncol (2005) 1.53
Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys (2009) 1.52
Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. AJNR Am J Neuroradiol (2002) 1.51
Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys (2010) 1.46
Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck (2002) 1.45
Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.44
Linear accelerator surgery for meningiomas. J Neurosurg (2005) 1.43
Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol (2014) 1.42
Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol (2006) 1.42
Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys (2002) 1.35
Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys (2006) 1.34
Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope (2009) 1.33
T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.32
Skull base chordoma. Head Neck (2005) 1.28
Salivary gland pleomorphic adenoma. Am J Clin Oncol (2008) 1.28
Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol (2006) 1.27
Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer (2005) 1.26
Head and neck paragangliomas. Head Neck (2010) 1.24
Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer (2006) 1.22
External beam radiotherapy for differentiated thyroid cancer. Am J Otolaryngol (2005) 1.21
Skin carcinoma of the head and neck with perineural invasion. Am J Otolaryngol (2011) 1.20
Mucosal melanoma of the head and neck. Am J Clin Oncol (2008) 1.19
The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys (2006) 1.18
Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med (2002) 1.17
Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol (2005) 1.17
Skin cancer of the head and neck with perineural invasion. Am J Clin Oncol (2007) 1.17
Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am J Clin Oncol (2005) 1.15
Adult head and neck soft tissue sarcomas. Head Neck (2005) 1.14
Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck (2002) 1.13
Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol (2013) 1.13
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck (2003) 1.13
Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapy. Head Neck (2012) 1.13
Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope (2009) 1.12
Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Laryngoscope (2009) 1.11
Ewing tumors of the head and neck. Am J Clin Oncol (2010) 1.11
Radiation therapy for angiosarcoma. Head Neck (2003) 1.11
Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy. Radiother Oncol (2010) 1.11